Search research articles
Contact Us
Filters
Showing results (431-440 of 547) with videos related to
Page
of 55
Sort By:
International Journal of Molecular Sciences
|
July 2, 2021
Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N<sub>2</sub> in Dendritic Cells to Protect from Elevated Colitis
Larissa Hering, Egle Katkeviciute, Marlene Schwarzfischer, et al.
Inflammatory Intestinal Diseases
|
November 1, 2021
A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis
Cheryl de Vallière, Katharina Bäbler, Philipp Busenhart, et al.
International Journal of Molecular Sciences
|
February 15, 2022
pH-Sensing G Protein-Coupled Receptor OGR1 (GPR68) Expression and Activation Increases in Intestinal Inflammation and Fibrosis
Cheryl de Vallière, Jesus Cosin-Roger, Katharina Baebler, et al.
Journal of Crohn'S & Colitis
|
November 16, 2013
Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study
Daniela Rogler, Nicolas Fournier, Valérie Pittet, et al.
Alimentary Pharmacology & Therapeutics
|
May 11, 2021
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease
Sebastian Bruno Ulrich Jordi, Federica Botte, Brian Matthew Lang, et al.
The American Journal of Clinical Nutrition
|
September 27, 2022
Novel lipid emulsion for total parenteral nutrition based on 18-carbon n-3 fatty acids elicits a superior immunometabolic phenotype in a murine model compared with standard lipid emulsions
Eliana Lucchinetti, Phing-How Lou, Gregory Holtzhauer, et al.
Inflammatory Bowel Diseases
|
February 19, 2019
Actual Anti-TNF Trough Levels Relate to Serum IL-10 in Drug-Responding Patients With Crohn's Disease
Pedro Zapater, Susana Almenara, Ana Gutiérrez, et al.
Neurogastroenterology and Motility
|
August 29, 2020
Responses to the Letter to the Editor by Brusciano et al
Jordi Serra, Daniel Pohl, Fernando Azpiroz, et al.
Inflammatory Bowel Diseases
|
June 16, 2011
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Stephan R Vavricka, Alain M Schoepfer, Georg Bansky, et al.
Alimentary Pharmacology & Therapeutics
|
November 7, 2020
Fatigue in inflammatory bowel disease and its impact on daily activities
Philipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, et al.
Page
of 55
Search research articles
Search
Showing results (431-440 of 547) with videos related to
Sort By:
Page
of 55
International Journal of Molecular Sciences
|
July 2, 2021
Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N<sub>2</sub> in Dendritic Cells to Protect from Elevated Colitis
Larissa Hering, Egle Katkeviciute, Marlene Schwarzfischer, et al.
Inflammatory Intestinal Diseases
|
November 1, 2021
A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis
Cheryl de Vallière, Katharina Bäbler, Philipp Busenhart, et al.
International Journal of Molecular Sciences
|
February 15, 2022
pH-Sensing G Protein-Coupled Receptor OGR1 (GPR68) Expression and Activation Increases in Intestinal Inflammation and Fibrosis
Cheryl de Vallière, Jesus Cosin-Roger, Katharina Baebler, et al.
Journal of Crohn'S & Colitis
|
November 16, 2013
Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study
Daniela Rogler, Nicolas Fournier, Valérie Pittet, et al.
Alimentary Pharmacology & Therapeutics
|
May 11, 2021
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease
Sebastian Bruno Ulrich Jordi, Federica Botte, Brian Matthew Lang, et al.
The American Journal of Clinical Nutrition
|
September 27, 2022
Novel lipid emulsion for total parenteral nutrition based on 18-carbon n-3 fatty acids elicits a superior immunometabolic phenotype in a murine model compared with standard lipid emulsions
Eliana Lucchinetti, Phing-How Lou, Gregory Holtzhauer, et al.
Inflammatory Bowel Diseases
|
February 19, 2019
Actual Anti-TNF Trough Levels Relate to Serum IL-10 in Drug-Responding Patients With Crohn's Disease
Pedro Zapater, Susana Almenara, Ana Gutiérrez, et al.
Neurogastroenterology and Motility
|
August 29, 2020
Responses to the Letter to the Editor by Brusciano et al
Jordi Serra, Daniel Pohl, Fernando Azpiroz, et al.
Inflammatory Bowel Diseases
|
June 16, 2011
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Stephan R Vavricka, Alain M Schoepfer, Georg Bansky, et al.
Alimentary Pharmacology & Therapeutics
|
November 7, 2020
Fatigue in inflammatory bowel disease and its impact on daily activities
Philipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, et al.
Page
of 55